News Quantified

BSGM – biosig technologies, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel [Yahoo! Finance]

BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

Form 8-K BioSig Technologies, For: Oct 18

Form 4 BioSig Technologies, For: Sep 11 Filed by: Amato Anthony N.

Form 8-K BioSig Technologies, For: Sep 11

Top News Gainers

4/3 BioSig to Host Telebriefing on Development Updates Regarding Vicromax(tm), a Novel Broad-Spectrum Anti-Viral Candidate That May Treat COVID-19 37.4%

4/21 BioSig Technologies Inc (NASDAQ: BSGM) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.00 price target on the stock. 15.6%

4/9 Positive Data Generated by Biosig Subsidiary ViralClear on Covid-19 Coronavirus Published in bioRxiv 15.1%

6/10 BioSig Technologies Set to Join Russell 3000® Index 13.6%

3/25 WHO Officials Indicating at Least 20 Vaccines in Development in Global Race for a Cure 12.2%

2/19 BioSig Completes 100th Patient Case with PURE EP(TM) System 11.4%

5/7 BioSig Technologies Pivotal Moment [Seeking Alpha] 9.5%

5/7 Form EFFECT BioSig Technologies, 9.4%

4/24 BioSig Subsidiary ViralClear Submits Investigational New Drug Application to the FDA for Phase II Clinical Trials for Merimepodib, an Orally Administered Treatment for Patients with COVID-19 8.7%

6/6 BioSig Allowed a U.S. Patent for PURE EP™ Simulator 8.2%

Top News Decliners

3/13 Form 10-K BioSig Technologies, For: Dec 31 -14.3%

3/26 BioSig Technologies Inc (NASDAQ: BSGM) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -14.2%

3/31 Over 35 Companies in Race to Develop Vaccine for COVID-19 Health Crises -13.4%

4/29 Form DEF 14A BioSig Technologies, For: Jun 26 -13.4%

2/20 BioSig Announces Proposed Public Offering of Common Stock -9.4%

2/19 Form 8-K BioSig Technologies, For: Feb 19 -8.7%

5/20 Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors -8.1%

4/1 BioSig Technologies Inc (NASDAQ: BSGM) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -7.6%

5/22 Form 4 BioSig Technologies, For: May 21 Filed by: LONDONER KENNETH L -6.3%

7/31 Form 10-Q BioSig Technologies, For: Jun 30 -6.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day